The FDA granted 510(k) clearance for iPredict-DR, an AI-powered screening software designed to detect more than mild diabetic retinopathy in adults with diabetes, according to a press release from iHealthScreen.The clearance was supported by data from a clinical validation trial that looked at “diagnostic performance, safety and usability.” The software uses AI to examine color retinal fundus images taken with…
Source: Healio News
